Pathological tau signatures and nuclear alterations in neurons, astrocytes and microglia in Alzheimer's disease, progressive supranuclear palsy, and dementia with Lewy bodies. (24th August 2022)

• Record Type: Journal Article
• Authors: Montalbano, Mauro; Majmundar, Lajja; Sengupta, Urmi; Fung, Leiana; Kayed, Rakez
• Is Part Of: Brain pathology. Volume 33:Number 1(2023)
• Page Start: n/a
• Page End: n/a
• Publication Date: 2022-08-24
• Subjects: glia -- neuron -- nuclei -- tau conformers -- tauopathies; Nervous system -- Diseases -- Periodicals; Brain -- Diseases -- Periodicals; Neurology -- Periodicals; Brain Diseases -- Periodicals; Cerveau -- Maladies -- Périodiques; Système nerveux -- Maladies -- Périodiques; Neurologie -- Périodiques; 616.805
• DOI: 10.1111/bpa.13112
• Languages: English
• ISSNs: 1015-6305

Abstract

Abstract: Accumulation of pathological tau aggregates is a prominent feature in tauopathies that leads during the course of the diseases to neuronal dysfunction before and cell death after. Microglia and astrocytes have been described as playing important roles in synaptic spreading of toxic tau in several neurodegenerative diseases (NDs). Here, we have investigated the immunological and biochemical properties of aggregated tau species in different brain cell types in tau‐induced neurodegenerative diseases such as Alzheimer's disease (AD), progressive supranuclear palsy (PSP), and dementia with Lewy bodies (DLB). Additionally, we examined nuclear size, nuclear density, and chromatin compaction in neuronal and glial cells from diseased brain tissues. Microscopic‐histological examination was performed using in‐house mouse monoclonal antibodies for t oxic t au c onformers (TTC‐M1 and TTC‐M2) and t au o ligomers (TOMA1‐4). By immunohistochemistry and co‐immunofluorescence assays using TOMA/TTC‐Ms and cell‐type specific markers for neurons, astrocytes, and microglia, we observed that TOMA/TTC‐Ms were immunoreactive to diverse tau species in different cell types. Analysis of colocalization coefficients indicated an increased pathological tau deposition mainly in the neurons. Western blot analysis of brain homogenates using TOMA/TTC‐Ms revealed distinct patterns of tau aggregation in each disease, suggesting that TOMA/TTC‐Ms can distinguish between different tau aggregates present in different tauopathies. Additionally, using DAPI staining, we observed that neuronal and astrocytic nuclei had significantly greater nuclear area and increased chromatin compaction in AD cortices compared to non‐demented controls. In contrast, reduction in nuclear density/area and more relaxed chromatin was noticed in DLB neurons, astrocytes and microglia and PSP astrocytes and microglia. Cell‐type specific tropism of toxic tau species in tauopathies will provide a greater understanding of the involvement of different brain cell types in tau pathology. In this study, we observed that each disease presented cell‐type specific nuclear phenotype and tau deposition pattern. Abstract : Schematic depicting characterization of pathological tau signatures and nuclear alterations in neurons, astrocytes and microglia in neurodegenerative diseases.